BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

39 related articles for article (PubMed ID: 8631192)

  • 1. Subdermal Progestin Implant and an Oral Combined Hormonal Contraceptive in Youth with Type 1 Diabetes.
    Giraudo F; Salinas A; Merino PM; Iñiguez G; López P; Castro A; Lardone MC; Cavada G; Cassorla F; Codner E
    J Pediatr Adolesc Gynecol; 2024 Apr; 37(2):177-183. PubMed ID: 38012981
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral contraceptives in adolescents: a retrospective population-based study on blood pressure and metabolic dysregulation.
    de Araújo PX; Moreira P; de Almeida DC; de Souza AA; do Carmo Franco M
    Eur J Clin Pharmacol; 2024 Jul; 80(7):1097-1103. PubMed ID: 38554180
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of oral contraceptives on resting autonomic function and the autonomic response to physiological stressors: a systematic review.
    Pereira TJ; Bouakkar J; Johnston H; Pakosh M; Drake JD; Edgell H
    Clin Auton Res; 2023 Dec; 33(6):859-892. PubMed ID: 37971640
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Call for papers: "Cardiovascular regulation during exercise: role of biological sex and consequences of aging".
    Stone AJ; Grotle AK; Stachenfeld NS
    Am J Physiol Regul Integr Comp Physiol; 2024 Feb; 326(2):R89-R90. PubMed ID: 38145291
    [No Abstract]   [Full Text] [Related]  

  • 5. Oestrogens and insulin secretion.
    Godsland IF
    Diabetologia; 2005 Nov; 48(11):2213-20. PubMed ID: 16193292
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Occlusive vascular diseases in oral contraceptive users. Epidemiology, pathology and mechanisms.
    Godsland IF; Winkler U; Lidegaard O; Crook D
    Drugs; 2000 Oct; 60(4):721-869. PubMed ID: 11085198
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral contraceptives and coronary heart disease: modulation of glucose tolerance and plasma lipid risk factors by progestins.
    Crook D; Godsland IF; Wynn V
    Am J Obstet Gynecol; 1988 Jun; 158(6 Pt 2):1612-20. PubMed ID: 3287933
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical and metabolic considerations of long-term oral contraceptive use.
    Godsland IF; Crook D; Wynn V
    Am J Obstet Gynecol; 1992 Jun; 166(6 Pt 2):1955-63. PubMed ID: 1605285
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationships between blood pressure, oral contraceptive use and metabolic risk markers for cardiovascular disease.
    Godsland IF; Crook D; Devenport M; Wynn V
    Contraception; 1995 Sep; 52(3):143-9. PubMed ID: 7587185
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of different formulations of oral contraceptive agents on lipid and carbohydrate metabolism.
    Godsland IF; Crook D; Simpson R; Proudler T; Felton C; Lees B; Anyaoku V; Devenport M; Wynn V
    N Engl J Med; 1990 Nov; 323(20):1375-81. PubMed ID: 2146499
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulin resistance, secretion, and metabolism in users of oral contraceptives.
    Godsland IF; Walton C; Felton C; Proudler A; Patel A; Wynn V
    J Clin Endocrinol Metab; 1992 Jan; 74(1):64-70. PubMed ID: 1530790
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A study of the interactive effects of oral contraceptive use and dietary fat intake on blood pressure, cardiovascular reactivity and glucose tolerance in normotensive women.
    Straznicky NE; Barrington VE; Branley P; Louis WJ
    J Hypertens; 1998 Mar; 16(3):357-68. PubMed ID: 9557929
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparative metabolic study of two low-estrogen-dose oral contraceptives containing desogestrel or gestodene progestins.
    Crook D; Godsland IF; Worthington M; Felton CV; Proudler AJ; Stevenson JC
    Am J Obstet Gynecol; 1993 Nov; 169(5):1183-9. PubMed ID: 8238183
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interaction of oral contraceptive use with the effects of age, exercise habits and other cardiovascular risk modifiers on metabolic risk markers.
    Godsland IF
    Contraception; 1996 Jan; 53(1):9-16. PubMed ID: 8631192
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.